Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Chemical Engineers are Beginning to Play a Leading Role in the Treatment of Cancers

Published: Monday, July 08, 2013
Last Updated: Monday, July 08, 2013
Bookmark and Share
Engineers are helping to combat drug resistance and finding better ways of delivering treatments directly at tumours.

Cancer treatments often include a mix of therapies including chemotherapy, growth inhibitors and radiation therapy.

Success is dependent on many factors, but multi-drug resistance by the cancerous cells and the inability to deliver chemotherapy treatments directly to tumours in high enough concentrations are just some of the obstacles to a successful outcome.

It’s a problem which is attracting the attention of chemical engineers who are looking at new ways to treat cancer. One example is using ‘nanomaterials’ to carry drugs into affected areas in combination with experimental photothermal therapies.

Nanomaterials, such as Nanographene oxide (NGO), are able to penetrate the relatively large gaps (100-600nm) found in tumours to target cancerous cells more effectively.  By changing the size and surface properties of the nanomaterials, chemical engineers are also able to control how the drugs are distributed around the body to help avoid damaging non-cancerous cells.

Drugs carried by nanomaterials have other distinct advantages over ‘small molecule drugs’, which are quickly metabolised and removed from the human body by the kidneys. Standard drugs also have greater side effects caused by the high dosages needed to treat the cancers.

A recent study1 by chemical engineers in Taiwan, using nanomaterials technology combined with other cancer treatments, were able to increase the local drug concentration six fold and suppress tumour development more efficiently. Their results also suggested treatment was less toxic, with reduced side effects, and no multi-drug resistance.

David Brown, chief executive of the Institution of Chemical Engineers (IChemE), said: “Recent analysis by the charity Macmillan Cancer Support projects that in 2020 nearly one in two people (47%) in the UK will get cancer in his or her lifetime.

“These are dramatic statistics and put increasing pressure on the health sector and professionals like chemical engineers to find better treatments and cures for cancer.

“It’s great to see chemical engineers making their own significant contribution in this field in this latest piece of research from Taiwan and other projects we know are underway in many other countries around the world.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Artificial Nose Matches Human Sense of Smell
Chemical engineers in South Korea have successfully created nanobioelectronic nose.
Monday, June 24, 2013
Scientific News
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
University of Glasgow Researchers Make An Impact in 60 Seconds
Early-career researchers were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Dead Bacteria to Kill Colorectal Cancer
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells.
CRISPR-Cas9 Gene Editing: Check Three Times, Cut Once
Two new studies from UC Berkeley should give scientists who use CRISPR-Cas9 for genome engineering greater confidence that they won’t inadvertently edit the wrong DNA.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos